Thermo Fisher Scientific Inc. announced that it has completed its acquisition of FEI Company, Inc. a manufacturer of high-performance electron microscopy, for $107.50 per share in cash, or a total purchase price of approximately $4.2 billion. The completion of the transaction follows the re ... more
Thermo Fisher Scientific’s Maybridge Line of Chemistry Products Celebrates 50 Years
Thermo Fisher Scientific Inc announced the 50th anniversary of its Maybridge chemistry products, a line of bioactive molecules to accelerate drug discovery and development. The Maybridge line is a comprehensive range of drug-like molecules and compound libraries for traditional drug-discovery screening, as well as fragment-based programs.
The Maybridge business, founded by organic chemist Dr. R.J. Bridgewater in 1962, became part of Thermo Fisher in 2002. The Maybridge line now encompasses more than 56,000 pre-plated drug-like screening compounds.
“We are very proud that after 50 years Maybridge products continue to enable discovery,” said Simon Pearce, product manager for Maybridge and Acros Organics products at Thermo Fisher. “We continue to evolve to better serve our customers and have just completed our move from Tintagel, England to the Thermo Fisher site in Loughborough, where we will further strengthen our core offerings and improve our service to our customers worldwide. Our new location will allow us to leverage the dedicated technical, supply-chain and operational teams that support other world-class Thermo Fisher Scientific chemical product lines.”
- Thermo Fisher Scientific
- drug discovery
Thermo Fisher Scientific Inc. officially opened its new global headquarters at 168 Third Avenue in Waltham, Mass. The company designed and constructed the new 286,000-square-foot facility in accordance with green building rating systems, making it eligible for LEED (Leadership in Energy & E ... more
Thermo Fisher Scientific Inc., and FEI Company announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of FEI for $107.50 per share in cash. The transaction represents a purchase price of approximately $4.2 billion. FEI designs, manufactures and suppor ... more
This new HPIC™ system offers reliable ion analysis with simplicity, stability and versatility. Increase productivity with 4um columns, enabling faster runs without sacrificing resolution more
Developed for flexibility, modularity, and ease-of-use, the Dionex ICS-5000+ HPIC system combines highest chromatographic resolution with convenience more
The new Chromeleon 7.2 CDS release is the first CDS that combines separation (GC/IC/LC) and Mass Spectrometry (MS) in an enterprise environment more
The Thermo Scientific™ Dionex™ Integrion™ HPIC™ System is a new HPIC platform with many features previously only available on high end ion chromatographs. This system has been designed with the user in mind, for simple, everyday IC analysis with a number of upgradable features so your syst ... more
Have you ever wondered why you need to use two different software packages for instruments that sit on the same bench in the same lab and the only difference is that one has a mass spectrometer (MS) for detection? Our customers told us that there is a big need to unify chromatography and MS ... more
The Vanquish UHPLC System… Designed with innovative technology and fine detail, the Thermo Scientific™ Vanquish™ UHPLC System delivers a new standard in high-end UHPLC—more results with better separations and easier interaction simultaneously, without compromise. Conceived for the uniquely ... more
Organizations have made significant investments in enterprise and laboratory tools, technologies and solutions to help improve productivity, better manage data/information and optimize their business processes. However, the reality is that most comp more
Join Dr. Cathy B. Moelans of the University Medical Center Utrecht and Dr. Sara Brown from Thermo Fisher Scientific as they describe sensitive detection and analysis of microRNAs using new TaqMan™ Advanced miRNA Assays.Webinar DetailsKey topics to be covered in this 1-hour webinar include:I ... moreWebinarOn-Demand
Watch our free on-demand webinar on immunoassay platform development for evaluating biomarkers relevant to autoimmune disease and cancer research. Discover how antibody-based multiplex tools augment your capacity to detect protein analytes in biological samples. Webinar details In this we ... moreWebinarOn-Demand
Join us as Piergiorgio Stevanato, PhD, from the University of Padova shares his journey using high-throughput OpenArray® technology on the QuantStudio® 12K Flex System to discover and validate SNP markers for effective genotyping in sugar beets. more
- 1Potential cause for lupus identified
- 2Peptide complex formed in the brain is responsible for Alzheimer's disease
- 3Why do BRCA1 mutations cause predominantly breast and ovarian cancer?
- 4LUM incorporates subsidiary in the Land of the rising sun
- 5Personalize your medication dosages
- 6The proton precisely weighted
- Tiny nanoparticles offer significant potential in detecting and treating disease
- New three-in-one blood test opens door to precision medicine for prostate cancer
- To be or not to be an academic: the question for all postdocs
- Epigenetic changes at birth could explain later behavior problems
- Nanotechnology reveals hidden depths of bacterial 'machines'